CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fredun Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fredun Pharmaceuticals Ltd
26 Manoj Industrial Premises
G D Ambekar Wadala
Phone: +91 2240318111p:+91 2240318111 MUMBAI, 400013  India Ticker: 539730539730
Business Summary
Fredun Pharmaceuticals Ltd. is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of dietary/herbal supplements, nutraceuticals, and other healthcare products, along with animal healthcare products. The Company's segment includes Fredun Generics, Pet Healthcare, Nutraceuticals and Dietary Supplements and Cosmeceuticals. Its Generics Division, marketed under the Fredun Gx brand. The Nutraceutical Division under Fredun Nutrition brand. The Pet Healthcare segment operates under the Freossi brand. The Cosmeceuticals Division, operating under the Bird N Beauty (BNB) and Beautyfred brands, is focused on skincare and personal care products. It offers a range of products, including antihypertensive, antidiabetic, antiretroviral drugs (ARVs) and narcotics. The Company primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Joint Managing Director Daulat N.Medhora 77 6/8/1987 6/8/1987
Chief Financial Officer, Managing Director, Executive Director Fredun N.Medhora 37 10/6/2021 10/15/2020
Compliance Officer, Company Secretary JinkalShah 1/28/2022 1/28/2022
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 254 (As of 3/31/2024)
Outstanding Shares: 4,721,662 (As of 9/30/2024)
Shareholders: 7,507
Stock Exchange: BOM
Fax Number: +91 2240318133


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024